NCT01795716View on ClinicalTrials.gov

Bioequivalence Study of Mesylate Imatinib Capsule in Chronic Myeloid Leukemia Body

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

September 30, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

June 30, 2013

Conditions
Chronic Myeloid Leukemia
Interventions
DRUG

mesylate imatinib capsule

Single and multiple oral mesylate imatinib capsule 400mg qd

DRUG

Glivec

Single and multiple oral Glivec 400mg qd

Trial Locations (1)

200025

Shanghai Jiaotong University School of Medicine Ruijin Hospital, Shanghai

Sponsors
All Listed Sponsors
lead

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

INDUSTRY